Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Directorate Change

12 Mar 2021 07:00

RNS Number : 0284S
Anpario PLC
12 March 2021
 

Anpario plc

("Anpario" or the "Company")

 

Directorate change

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity is pleased to announce the appointment of Ian (John) Hamilton as a Non-Executive Director of the Company with effect from 1 April 2021.

 

Ian has an extensive track record of senior-executive and Non-Executive experience in the animal genetics and specialty feed additive industries. As a member of the founding management team of Aviagen, he played a pivotal role in building the business through organic and acquisition growth to become the world's largest poultry breeding business. Ian has supported several blue-chip investment houses targeting the Agribusiness and Agtech sector. In addition, he was a consultant to Anitox Ltd, a formaldehyde pathogen control business for raw material and animal feed hygiene applications.

 

Ian is currently Non-Executive Chairman of Horizon Proteins Ltd, which provides sustainable proteins for aquaculture recycled from the whiskey-making process, and Biotangents Ltd, a veterinary diagnostics business.

 

Peter Lawrence, Chairman, stated:

 

"We are delighted Ian will be joining the Board as a Non-Executive Director bringing valuable commercial experience and an extensive network across the global animal production and agri-tech industries. Ian's appointment reflects Anpario's strategy to build strong commercial relationships with key producers through our regional sales structure and enhance our organic growth with complementary acquisitions."

 

The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies:

 

John ("Ian") Hamilton (aged 57) holds or has held the following directorships or partnerships in the past five years:

Current directorships/appointments

Biotangents Limited

Director

Horizon Proteins Limited

Director

HP Technology Limited

Director

Ovatech limited (China)

Director

WAVE AG TECH PTY Limited (Australia)

Director

Vytelle LLC (US)

Director

Vytelle Holdings LLC (US)

Director

 

Past directorships/appointments

Dairy Daughters Limited 1

Director

World Wide Sires Limited 2

Director

Accelerated Genetics Limited 3

Director

Five Star Breeders Limited 4

Director

Select Sires Limited 5

Director

Cogent Breeding Limited

Director

Zantra Limited Ltd

Director

Aurora Orkney Limited

Director

Golf Galleries Limited

Director

Roslin Technologies Limited

Director

Grosvenor garden Centre Limited

Director

OWS Agri Limited

Director

The Adwill Partnership Limited 6

Director

GrowSafe Systems Limited (Canada)

Director

 

1 Dairy Daughters Limited was dissolved via voluntary strike-off 7 February 2017

2 World Wide Sires Limited was dissolved via voluntary strike-off 30 August 2016

3 Accelerated Genetics Limited was dissolved via voluntary strike-off 7 February 2017

4 Five Star Breeders Limited was dissolved via voluntary strike-off 30 August 2016

5 Select Sires Limited was dissolved via voluntary strike-off 30 August 2016

6 The Adwill Partnership Limited was dissolved via compulsory liquidation on 26 September 2020

 

There is no further information required to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Karen Prior, Group Finance Director

+44(0) 1909 537380

Peel Hunt LLP (NOMAD)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAFDFFFSFEAA
Date   Source Headline
18th Jun 202612:35 pmRNSResult of AGM
18th Jun 20267:00 amRNSAGM Statement
11th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
15th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
14th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
12th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
11th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
6th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
5th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Apr 20267:00 amRNSLaunch of Share Buyback Programme
10th Apr 202612:00 pmRNSInvestor Presentation via Investor Meet Company
31st Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSHolding(s) in Company
19th Jan 20263:44 pmRNSBlock listing return
19th Jan 20267:00 amRNSFull year trading statement
23rd Sep 20257:00 amRNSChange of Auditor
10th Sep 20257:00 amRNSInterim Results
9th Sep 202511:36 amRNSInvestor Presentation via Investor Meet Company
22nd Jul 20257:00 amRNSJSOP Awards and TVR
17th Jul 20251:15 pmRNSBlock listing return
19th Jun 20252:01 pmRNSResult of AGM
19th Jun 20257:00 amRNSAGM Statement
19th May 20255:33 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20257:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSLaunch of Share Buyback Programme
2nd Apr 20257:00 amRNSAward Exercise, Voting Rights & Director Dealing
31st Mar 20257:00 amRNSFinal Results
26th Mar 20257:00 amRNSUpdate on Timing of Full Year Results Announcement
15th Jan 20257:00 amRNSGrant of options under SAYE Scheme
10th Jan 20257:00 amRNSFull year trading statement
9th Jan 20257:00 amRNSTotal Voting Rights
16th Dec 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.